{
    "2018-07-24": [
        [
            {
                "time": "2018-07-24",
                "original_text": "Citron's Left reiterates belief AbbVie shares will fall sharply",
                "features": {
                    "keywords": [
                        "Citron",
                        "reiterates",
                        "belief",
                        "AbbVie",
                        "fall",
                        "sharply"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-07-24",
                "original_text": "AbbVie prices new endometriosis drug at $10,000 a year",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "prices",
                        "endometriosis",
                        "drug",
                        "$10,000",
                        "year"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-07-24",
                "original_text": "Is a Beat in the Cards for AbbVie (ABBV) in Q2 Earnings?",
                "features": {
                    "keywords": [
                        "Beat",
                        "Cards",
                        "AbbVie",
                        "Q2",
                        "Earnings"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-24",
                "original_text": "Merck (MRK) Q2 Earnings Coming Up: What's in the Cards?",
                "features": {
                    "keywords": [
                        "Merck",
                        "Q2",
                        "Earnings",
                        "Coming",
                        "Cards"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-24",
                "original_text": "AbbVie Wins U.S. Approval for Endometriosis Pain Treatment",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Wins",
                        "U.S.",
                        "Approval",
                        "Endometriosis",
                        "Pain",
                        "Treatment"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-07-24",
                "original_text": "AbbVie Gets FDA Approval for Potential Blockbuster Endometriosis Treatment",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Gets",
                        "FDA",
                        "Approval",
                        "Blockbuster",
                        "Endometriosis",
                        "Treatment"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-07-24",
                "original_text": "What's in Store for Cardinal Health (CAH) in Q4 Earnings?",
                "features": {
                    "keywords": [
                        "Cardinal",
                        "Health",
                        "Q4",
                        "Earnings"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-24",
                "original_text": "Eli Lilly Surpasses Estimates, Reports Growth in Q2 2018",
                "features": {
                    "keywords": [
                        "Eli",
                        "Lilly",
                        "Surpasses",
                        "Estimates",
                        "Growth",
                        "Q2",
                        "2018"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-07-24",
                "original_text": "J&Jâ€™s Oncology Franchise Saw 42.2% Growth in Q2 2018",
                "features": {
                    "keywords": [
                        "J&J",
                        "Oncology",
                        "Franchise",
                        "Growth",
                        "Q2",
                        "2018"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-07-24",
                "original_text": "Will Strong HIV Sales Fuel Gilead (GILD) In Q2 Earnings?",
                "features": {
                    "keywords": [
                        "Strong",
                        "HIV",
                        "Sales",
                        "Fuel",
                        "Gilead",
                        "Q2",
                        "Earnings"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}